Bendamustine and Rituximab Combo Shines in Indolent Lymphoma Medscape June 3, 2012 (Chicago, Illinois) — New long-term results from a German trial of patients with indolent and slow-growing lymphoma confirm that a simpler 2-drug combination can be used in these patients instead of a more aggressive chemotherapy approach. |
